Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio" or the "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory ...

BOSTON and LAUSANNE, Switzerland, March 27, 2025 /PRNewswire/ -- Alys Pharmaceuticals, Inc. ("Alys"), an immune-dermatology focused company, today announces that the first patient has been dosed ...

For these patients, hair isn’t just hair — it’s a daily reminder of a struggle they never chose. Yet, in Maryland, thousands of residents suffering from conditions like alopecia areata ...

Unique siRNA platform, developed with Nobel Prize Laureate Craig Mello, offers potential for treating multiple dermatology indications ALY-101 is formulated as an intradermal injectable for the ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from ...